Veronica Hackethal, MD
Apolipoprotein(a): What Role in Atrial Fibrillation?
Is elevated Lp(a) a risk factor for ischemic stroke in persons with atrial fibrillation? Results of this ARIC analysis explain.
Can Follow-up Hemodynamic Variables Predict Outcome in PAH?
Results of a new study suggest that stroke volume index may be the better hemodynamic variable to monitor in PAH – not cardiac index.
Can Follow-up Hemodynamic Variables Predict Outcome in PAH?
Results of a new study suggest that stroke volume index may be the better hemodynamic variable to monitor in PAH – not cardiac index.
Selexipag Delays PAH Progression in Patients with Connective Tissue Disease
Results of a subgroup analysis from the GRIPHON trial are promising for a hard-to-treat population.
New Biomarker Could Improve ARDS, AHF Diagnosis
A biomarker of myocardial strain and inflammation may be able to discriminate between two similar pulmonary emergencies.
Quiz: 2017 ACC/AHA/HFSA Update to 2013 HF Guidelines
Test your recall of the most recent amendments to the heart failure guidelines on prevention, treatment of hypertension, and comorbidities.
Methamphetamine-associated PAH: First Prospective Cohort Study
Methamphetamine abuse is on a steady rise in the US. A new study highlights the nature and dangers of Meth-PAH.
No Difference in CV Outcomes with Statin plus Add-on vs Statin Alone
The HIJ-PROPER study found intensive LDL-lowering therapy added no additional therapeutic value in patients with ACS.
Hellenic Heart Failure Study: Impact of Mediterranean Diet on Recurrent ACS
Results of this study suggest a role for the anti-inflammatory diet in secondary prevention.
Toward Improved Risk Stratification in Pulmonary Arterial Hypertension
A new study supports the utility of pulmonary arterial proportional pulse pressure to predict 5-year mortality in patients with PAH.